Top Markets
#1 OVERTAKE OVERTAKE +73.62%
#2 Clearpool Clearpool +29.52%
#3 Playnance Playnance +28.03%
#4 Concordium Concordium +26.26%
#5 B3 (Base) B3 (Base) +18.85%
#6 deBridge deBridge +17.03%
#7 Nillion Nillion +15.91%
#8 龙虾 (Lobster) 龙虾 (Lobster) +15.01%
#9 PondCoin PondCoin +12.24%
#10 Arcblock Arcblock +12.17%
Coin of the day
OVERTAKE OVERTAKE
Settings
Language
ENGLISH
Currency
USD
Theme
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Rank in Stocks #23
Johnson & Johnson is a holding company, which engages in the research,... Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Share Price
$267.84
Market Cap
$645.47B
Change (1 day)
-0.63%
Change (1 year)
51.68%
Country
US
Trade Johnson & Johnson (JNJ)

Category

Healthcare
Number of shares outstanding for Johnson & Johnson (JNJ)
Number of shares outstanding as of June 2026: 2.44B
According to Johnson & Johnson latest financial reports and stock price the company's current number of shares outstanding is 2.44B. At the end of December 2024 the company had 2.41B shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Johnson & Johnson (JNJ) from 2000 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 2.44B 0.48%
2025 2.43B 0.88%
2024 2.41B -4.98%
2023 2.53B -3.63%
2022 2.63B -0.13%
2021 2.63B 0.00%
2019 2.63B -1.12%
2018 2.66B -0.75%
2017 2.68B -0.89%
2016 2.71B -1.77%
2015 2.76B -1.01%
2014 2.78B -1.33%
2013 2.82B 1.52%
2012 2.78B 1.99%
2011 2.72B -0.50%
2010 2.74B -0.79%
2009 2.76B -1.85%
2008 2.81B -2.46%
2007 2.88B -1.93%
2006 2.94B -1.23%
2005 2.98B 0.28%
2004 2.97B 0.00%
2003 2.97B -1.02%
2002 3.00B -1.07%
2001 3.03B 1.25%
2000 2.99B 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 892.40M -63.43%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.77B -27.42%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 796.00M -67.38%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 0.00 -100.00%
US
Novartis AG Novartis AG
Novartis AG
NOVN.SW
 1.91B -21.60%
CH